Physician profile
John Mccaffery
NPI 1770537631
$1,771.43
in general payments reported to CMS, 2019-2025
11 companies · $728 in 2025
The $728 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.68 · 2020: $500 · 2021: $35.99 · 2022: $39.33 · 2023: $74.37 · 2024: $356 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $682.41 | 2021-2025 | |
| Karl Storz Imaging, INC. | $500.00 | 2020 | |
| Glaxosmithkline, LLC. | $175.63 | 2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $135.58 | 2025 | Dupixent |
| Stryker Corporation | $88.66 | 2019-2025 | Audion Et Dilation System |
| Astrazeneca Pharmaceuticals LP | $64.81 | 2025 | Tezspire |
| Medtronic, INC. | $35.51 | 2022-2023 | Propel |
| Cochlear Americas | $28.95 | 2023 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Carestream Dental, LLC | $23.02 | 2021 | |
| Acera Surgical, INC. | $20.44 | 2025 | Restrata Wound Matrix |
| Livanova USA, INC. | $16.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mccaffery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.